Clinical Trial

Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia

Study acronym: ALIGN-AML
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and improves patient-centered outcomes compared with usual oncologist-directed care in adults aged 60 years and older with newly diagnosed AML.
Trial Details
NCT Number NCT07735208
Lead Sponsor University of Rochester
Collaborators: Rising Tide Foundation
Conditions Acute Myeloid Leukemia
Enrollment 120 participants
Start Date 2026-12-01
Primary Completion 2031-11-30 (estimated)
Study Completion 2031-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-29